PMLiVEcom Profile Banner
Pharmaceutical Market Europe Profile
Pharmaceutical Market Europe

@PMLiVEcom

Followers
16K
Following
358
Media
634
Statuses
21K

News & analysis of healthcare, pharma and biotech. Magazines, directories, profiles, jobs & awards.

Surrey, UK
Joined June 2009
Don't wanna be here? Send us removal request.
@PMLiVEcom
Pharmaceutical Market Europe
6 hours
Abivax shares positive late-stage results for obefazimod in ulcerative colitis
Tweet card summary image
pmlive.com
Inflammatory bowel disease affects nearly one in every 100 people in the US
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
6 hours
LEO’s Anzupgo granted FDA approval to treat moderate-to-severe chronic hand eczema
Tweet card summary image
pmlive.com
The cream is now the first treatment approved by the regulator specifically for this patient population
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
6 hours
Johnson & Johnson’s Darzalex approved by EC as first treatment for high-risk SMM
pmlive.com
The early precursor of active multiple myeloma accounts for around 15% of all new multiple myeloma cases
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
16 hours
Honoring the Legacy of Dr. Robert Sidbury, MD, MPH
Tweet card summary image
pmlive.com
We are deeply saddened by the recent passing of Dr. Robert Sidbury.
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
1 day
NICE recommends ALK’s immunotherapy to target underlying cause of hay fever
Tweet card summary image
pmlive.com
An estimated 26,800 people in England with moderate-to-severe cases could benefit from Itulazax
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
1 day
Roche’s Itovebi granted EC approval to treat advanced breast cancer patients
Tweet card summary image
pmlive.com
Hormone receptor-positive breast cancer accounts for around 70% of all breast cancer cases
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
1 day
AstraZeneca unveils plans to boost US footprint with $50bn investment
Tweet card summary image
pmlive.com
The funds will go towards establishing a multi-billion dollar drug substance facility in Virginia
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
2 days
Eli Lilly/Almirall’s Ebglyss shows promise in atopic dermatitis patients with darker skin tones
Tweet card summary image
pmlive.com
The inflammatory skin condition occurs in approximately 7.3% of adults in the US
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
2 days
Biogen to boost US manufacturing footprint with $2bn North Carolina investment
Tweet card summary image
pmlive.com
The commitment is aimed at advancing the company's late-stage clinical pipeline
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
2 days
Sanofi to expand respiratory vaccines pipeline with $1.6bn Vicebio acquisition
Tweet card summary image
pmlive.com
The deal includes an early-stage combination vaccine candidate for RSV and hMPV
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
2 days
In the latest issue of PME, Karen Harris explores how current market challenges are redefining the biotech landscape. Check out her article below: #Biotech #DrugFunding #Pharma #Health #PME.
Tweet card summary image
pmlive.com
Short-term uncertainty is slowing investment activity, but the long-term outlook remains strong
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
2 days
US Payer Panel Insights Survey: Evolving Evidence Landscape and Priorities
Tweet card summary image
pmlive.com
Download the first edition of the Petauri ‘US Payer Panel Insights Survey: Evolving Evidence Landscape and Priorities’ report
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
3 days
EC approves SpringWorks Therapeutics’ Ezmekly to treat rare genetic disorder NF1
Tweet card summary image
pmlive.com
Neurofibromatosis type 1 affects an estimated 135,000 people in the EU
0
1
0
@PMLiVEcom
Pharmaceutical Market Europe
3 days
AstraZeneca shares late-stage results for Tagrisso combination in lung cancer
Tweet card summary image
pmlive.com
An estimated 2.4 million people globally are diagnosed with lung cancer each year
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
3 days
In Uptake's latest column, Jo Lopez explores how integrating AI across the commercialisation process can drive better outcomes: #HealthcareComms #HealthcareMarketing #AIinPharma #DrugLaunch #Pharma #Health #PME.
Tweet card summary image
pmlive.com
How integrating AI across the commercialisation process can drive better outcomes
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
3 days
LEO Pharma gains access to Boehringer’s skin disease drug for €90m upfront
Tweet card summary image
pmlive.com
Spevigo is already approved in over 40 countries to treat generalised pustular psoriasis
0
1
0